BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng Z, Li X, Ding J. Characteristics of liver cancer stem cells and clinical correlations. Cancer Lett 2016;379:230-8. [PMID: 26272183 DOI: 10.1016/j.canlet.2015.07.041] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Kahraman DC, Bilget Guven E, Aytac PS, Aykut G, Tozkoparan B, Cetin Atalay R. A new triazolothiadiazine derivative inhibits stemness and induces cell death in HCC by oxidative stress dependent JNK pathway activation. Sci Rep 2022;12:15139. [PMID: 36071119 DOI: 10.1038/s41598-022-17444-0] [Reference Citation Analysis]
2 Li H, Sun Y, Li Q, Luo Q, Song G. Matrix Stiffness Potentiates Stemness of Liver Cancer Stem Cells Possibly via the Yes-Associated Protein Signal. ACS Biomater Sci Eng 2022. [PMID: 35084830 DOI: 10.1021/acsbiomaterials.1c00558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Xu C, Sun W, Liu J, Pu H, Li Y. MiR-342-3p inhibits LCSC oncogenicity and cell stemness through HDAC7/PTEN axis. Inflamm Res 2021. [PMID: 34842937 DOI: 10.1007/s00011-021-01521-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Lv D, Chen L, Du L, Zhou L, Tang H. Emerging Regulatory Mechanisms Involved in Liver Cancer Stem Cell Properties in Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:691410. [PMID: 34368140 DOI: 10.3389/fcell.2021.691410] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Gan G, Shi Z, Liu D, Zhang S, Zhu H, Wang Y, Mi J. 3-hydroxyanthranic acid increases the sensitivity of hepatocellular carcinoma to sorafenib by decreasing tumor cell stemness. Cell Death Discov 2021;7:173. [PMID: 34230478 DOI: 10.1038/s41420-021-00561-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Wei H, Wang J, Xu Z, Li W, Wu X, Zhuo C, Lu Y, Long X, Tang Q, Pu J. Hepatoma Cell-Derived Extracellular Vesicles Promote Liver Cancer Metastasis by Inducing the Differentiation of Bone Marrow Stem Cells Through microRNA-181d-5p and the FAK/Src Pathway. Front Cell Dev Biol 2021;9:607001. [PMID: 34124029 DOI: 10.3389/fcell.2021.607001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ning D, Chen J, Du P, Liu Q, Cheng Q, Li X, Zhang B, Chen X, Jiang L. The crosstalk network of XIST/miR-424-5p/OGT mediates RAF1 glycosylation and participates in the progression of liver cancer. Liver Int 2021;41:1933-44. [PMID: 33909326 DOI: 10.1111/liv.14904] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Liu F, Qian Y. The role of CD133 in hepatocellular carcinoma. Cancer Biol Ther 2021;22:291-300. [PMID: 33899676 DOI: 10.1080/15384047.2021.1916381] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 He C, Jaffar Ali D, Aseervatham G SB, Sun B, Xiao Z. Microvesicles - promising tiny players' of cancer stem cells targeted liver cancer treatments: The interesting interactions and therapeutic aspects. Pharmacol Res 2021;169:105609. [PMID: 33852962 DOI: 10.1016/j.phrs.2021.105609] [Reference Citation Analysis]
10 Xiao T, Luo Z, Guo Z, Wang X, Ding M, Wang W, Shen X, Zhao Y. Multiple Roles of Black Raspberry Anthocyanins Protecting against Alcoholic Liver Disease. Molecules 2021;26:2313. [PMID: 33923467 DOI: 10.3390/molecules26082313] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
11 Sun Y, Li H, Chen Q, Luo Q, Song G. The distribution of liver cancer stem cells correlates with the mechanical heterogeneity of liver cancer tissue. Histochem Cell Biol 2021;156:47-58. [PMID: 33710418 DOI: 10.1007/s00418-021-01979-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Cheng Z, Liang X, Zhang C, Wang R, Wei T, Ning B, Poreba E, Li L, Wang H, Ding J. SOX9-transactived long non-coding RNA NEAT1 promotes the self-renewal of liver cancer stem cells through PKA/Hippo signaling. Signal Transduct Target Ther 2021;6:87. [PMID: 33633109 DOI: 10.1038/s41392-021-00466-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang X, Xu N, Li Q, Chen S, Cheng H, Yang M, Jiang T, Chu J, Ma X, Yin D. Lactonic sophorolipid-induced apoptosis in human HepG2 cells through the Caspase-3 pathway. Appl Microbiol Biotechnol 2021;105:2033-42. [PMID: 33582833 DOI: 10.1007/s00253-020-11045-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhou T, Li S, Xiang D, Liu J, Sun W, Cui X, Ning B, Li X, Cheng Z, Jiang W, Zhang C, Liang X, Li L, Cheng X, Hui L, Wang H, Ding J. m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance. Signal Transduct Target Ther 2020;5:296. [PMID: 33361765 DOI: 10.1038/s41392-020-00299-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
15 Li Y, Chen G, Han Z, Cheng H, Qiao L, Li Y. IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells. Onco Targets Ther 2020;13:9721-30. [PMID: 33061451 DOI: 10.2147/OTT.S262089] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
16 Wan Z, Liu T, Wang L, Wang R, Zhang H. MicroRNA-216a-3p promotes sorafenib sensitivity in hepatocellular carcinoma by downregulating MAPK14 expression. Aging (Albany NY) 2020;12:18192-208. [PMID: 33021963 DOI: 10.18632/aging.103670] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Liu W, Yin C, Liu Y. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis. Cancer Biother Radiopharm 2020. [PMID: 32673066 DOI: 10.1089/cbr.2019.3472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
18 Shi DM, Shi XL, Xing KL, Zhou HX, Lu LL, Wu WZ. miR-296-5p suppresses stem cell potency of hepatocellular carcinoma cells via regulating Brg1/Sall4 axis. Cell Signal 2020;72:109650. [PMID: 32320856 DOI: 10.1016/j.cellsig.2020.109650] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
19 Wu Y, Zhang J, Zhang X, Zhou H, Liu G, Li Q. Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy. Front Pharmacol 2020;11:198. [PMID: 32210805 DOI: 10.3389/fphar.2020.00198] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
20 Liu S, Cheng K, Zhang H, Kong R, Wang S, Mao C, Liu S. Methylation Status of the Nanog Promoter Determines the Switch between Cancer Cells and Cancer Stem Cells. Adv Sci (Weinh) 2020;7:1903035. [PMID: 32154082 DOI: 10.1002/advs.201903035] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
21 Zhang H, Zhuo C, Zhou D, Zhang M, Zhang F, Chen M, Xu S, Chen Z. Small Nucleolar RNA Host Gene 1 (SNHG1) and Chromosome 2 Open Reading Frame 48 (C2orf48) as Potential Prognostic Signatures for Liver Cancer by Constructing Regulatory Networks. Med Sci Monit 2020;26:e920482. [PMID: 32036380 DOI: 10.12659/MSM.920482] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Kim BH, Park JW, Kim JS, Lee SK, Hong EK. Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma. Gut Liver. 2019;13:342-348. [PMID: 30600675 DOI: 10.5009/gnl18345] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
23 Wang X, Wang R, Bai S, Xiong S, Li Y, Liu M, Zhao Z, Wang Y, Zhao Y, Chen W, Billiar TR, Cheng B. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway. J Exp Clin Cancer Res 2019;38:505. [PMID: 31888685 DOI: 10.1186/s13046-019-1508-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
24 Zhao Y, Zhu Z, Shi S, Wang J, Li N. Long non-coding RNA MEG3 regulates migration and invasion of lung cancer stem cells via miR-650/SLC34A2 axis. Biomed Pharmacother 2019;120:109457. [PMID: 31585300 DOI: 10.1016/j.biopha.2019.109457] [Cited by in Crossref: 13] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
25 Wang Y, Wu G, Fu X, Xu S, Wang T, Zhang Q, Yang Y. Aquaporin 3 maintains the stemness of CD133+ hepatocellular carcinoma cells by activating STAT3. Cell Death Dis 2019;10:465. [PMID: 31197130 DOI: 10.1038/s41419-019-1712-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
26 Li B, Liu D, Yang P, Li HY, Wang D. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway. Gene 2019;707:78-85. [PMID: 31075412 DOI: 10.1016/j.gene.2019.05.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
27 Ran R, Chen J, Cui L, Lin X, Fan M, Cong Z, Zhang H, Tan W, Zhang G, Zhang Y. miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway. Experimental Cell Research 2019;378:66-75. [DOI: 10.1016/j.yexcr.2019.03.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
28 Wang F, Qi X, Li Z, Jin S, Xie Y, Zhong H. lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma. Cancer Manag Res 2019;11:3813-28. [PMID: 31118799 DOI: 10.2147/CMAR.S197673] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
29 Yang C, Cai W, Dong Z, Guo J, Zhao Y, Sui C, Yang J. lncARSR promotes liver cancer stem cells expansion via STAT3 pathway. Gene 2019;687:73-81. [DOI: 10.1016/j.gene.2018.10.087] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
30 Liang C, Yang P, Han T, Wang RY, Xing XL, Si AF, Ma QY, Chen Z, Li HY, Zhang B. Long non-coding RNA DILC promotes the progression of gallbladder carcinoma. Gene 2019;694:102-10. [PMID: 30716440 DOI: 10.1016/j.gene.2018.12.086] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
31 Li N, Zhu Y. Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma. Therap Adv Gastroenterol 2019;12:1756284818821560. [PMID: 30719075 DOI: 10.1177/1756284818821560] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
32 Cheng Z, Lei Z, Yang P, Si A, Xiang D, Zhou J, Hüser N. Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway. Gene 2019;684:95-103. [PMID: 30359743 DOI: 10.1016/j.gene.2018.10.051] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
33 Cheng Z, Lei Z, Yang P, Si A, Xiang D, Zhou J, Hüser N. Long non-coding RNA THOR promotes cell proliferation and metastasis in hepatocellular carcinoma. Gene 2018;678:129-36. [PMID: 30098425 DOI: 10.1016/j.gene.2018.08.035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
34 Xiang X, Deng L, Xiong R, Xiao D, Chen Z, Yang F, Liu K, Feng G. Tex10 is upregulated and promotes cancer stem cell properties and chemoresistance in hepatocellular carcinoma. Cell Cycle 2018;17:1310-8. [PMID: 30045663 DOI: 10.1080/15384101.2018.1480208] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
35 Chen D, Yu D, Wang X, Liu Y, He Y, Deng R, Jiang Y, Zhang F, Liu Y, Xu M, Li J, Luo J, Wang S. Epithelial to mesenchymal transition is involved in ethanol promoted hepatocellular carcinoma cells metastasis and stemness. Mol Carcinog 2018;57:1358-70. [PMID: 30295962 DOI: 10.1002/mc.22850] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
36 Sun J, Luo Q, Liu L, Song G. Low-level shear stress promotes migration of liver cancer stem cells via the FAK-ERK1/2 signalling pathway. Cancer Lett 2018;427:1-8. [PMID: 29678550 DOI: 10.1016/j.canlet.2018.04.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
37 Sequera C, Manzano S, Guerrero C, Porras A. How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinoma. Hepat Oncol 2018;5:HEP05. [PMID: 30302196 DOI: 10.2217/hep-2017-0026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
38 Hou X, Ye F, Li X, Liu W, Jing Y, Han Z, Wei L. Immune response involved in liver damage and the activation of hepatic progenitor cells during liver tumorigenesis. Cellular Immunology 2018;326:52-9. [DOI: 10.1016/j.cellimm.2017.08.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
39 Qian H, Ding X, Zhang J, Mao F, Sun Z, Jia H, Yin L, Wang M, Zhang X, Zhang B, Yan Y, Zhu W, Xu W. Cancer stemness and metastatic potential of the novel tumor cell line K3: an inner mutated cell of bone marrow-derived mesenchymal stem cells. Oncotarget 2017;8:39522-33. [PMID: 28465472 DOI: 10.18632/oncotarget.17133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
40 El-marakby EM, Hathout RM, Taha I, Mansour S, Mortada ND. A novel serum-stable liver targeted cytotoxic system using valerate-conjugated chitosan nanoparticles surface decorated with glycyrrhizin. International Journal of Pharmaceutics 2017;525:123-38. [DOI: 10.1016/j.ijpharm.2017.03.081] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
41 Xiang D, Cheng Z, Liu H, Wang X, Han T, Sun W, Li X, Yang W, Chen C, Xia M, Liu N, Yin S, Jin G, Lee T, Dong L, Hu H, Wang H, Ding J. Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients. Hepatology 2017;65:1566-80. [PMID: 28059452 DOI: 10.1002/hep.28919] [Cited by in Crossref: 85] [Cited by in F6Publishing: 94] [Article Influence: 17.0] [Reference Citation Analysis]
42 Nio K, Yamashita T, Kaneko S. The evolving concept of liver cancer stem cells. Mol Cancer. 2017;16:4. [PMID: 28137313 DOI: 10.1186/s12943-016-0572-9] [Cited by in Crossref: 84] [Cited by in F6Publishing: 99] [Article Influence: 16.8] [Reference Citation Analysis]
43 Mercer KE, Pulliam CF, Pedersen KB, Hennings L, Ronis MJ. Soy protein isolate inhibits hepatic tumor promotion in mice fed a high-fat liquid diet. Exp Biol Med (Maywood) 2017;242:635-44. [PMID: 28056552 DOI: 10.1177/1535370216685436] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
44 López-Gómez M, Casado E, Muñoz M, Alcalá S, Moreno-Rubio J, D'Errico G, Jiménez-Gordo AM, Salinas S, Sainz B Jr. Current evidence for cancer stem cells in gastrointestinal tumors and future research perspectives. Crit Rev Oncol Hematol 2016;107:54-71. [PMID: 27823652 DOI: 10.1016/j.critrevonc.2016.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]